• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

STUDY ON THE NON-INVASIVE DIAGNOSTIC SYSTEM OF HYPOXIC CELLS IN THE TUMOR BY NEAR-INFRARED SPECTROSCOPY

Research Project

Project/Area Number 10470198
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionTOKAI UNIVERSITY

Principal Investigator

MURAYAMA Chieko  TOKAI UNIV.SCHOOL OF MEDICINE, ASSISTANT RESEARCHER, 医学部, 助手 (50307295)

Co-Investigator(Kenkyū-buntansha) SUZUKI Yutaka  SCHOOL OF MEDICINE, PROFESSOR, 医学部, 教授 (70019967)
IMAMIYA Satoshi  SCHOOL OF MEDICINE, ASSISTANT RESEARCHER, 医学部, 助手 (30276844)
OHIZUMI Yukio  SCHOOL OF MEDICINE, ASSOCIATE PROFESSOR, 医学部, 助教授 (30024813)
KUTSUZAWA Tomoko  SCHOOL OF HEALTH SCIENCE, ASSOCIATE PROFESSOR, 健康科学部, 助教授 (10183310)
HAIDA Munetaka  SCHOOL OF MEDICINE, ASSISTANT PROFESSOR, 医学部, 講師 (20208408)
Project Period (FY) 1998 – 2000
KeywordsHYPOXIC CELLS / OXYGEN SATURATION / NEAR-INFRARED LIGHT / OXY-HEMOGLOBIN / DEOXY-HEMOGLOBIN / SPECT / ANTI-PIMONIDAZOLE ANTIBODY
Research Abstract

THERE ARE HYPOXIC CELLS IN THE TUMOR AS A RESISTANCE FACTOR OF TREATMENT FOR A RADIATION.IT IS IMPORTANT TO KNOW THE RATE OF HYPOXIC CELLS IN THE TUMOR, THAT IS, OXYGEN CONDITION OF THE TUMOR FOR THE DECISION OF THE TREATMENT PRINCIPLE.
BY THIS REASON, BEFORE AND DURING A RADIATION TREATMENT, A DEGREE OF OXYGEN SATURATION IN THE TUMOR OF PATIENTS IS MEASURED BY USING NEAR-INFRARED SPECTROSCOPY AND RELATION WITH EFFECT ON TREATMENT IS EXAMINED.AS A RESULT OF MEASURING A DEGREE OF OXYGEN SATURATION IN THE TUMOR WITH NON INVASIVE OXYGENATION MONITOR (OM-200, SHIMADZU) AND OMEGAOXYMETER (OMEGAMONITOR, BOM-L1), IT COULD SHOW A TENDENCY TO GET THE GOOD TUMOR REDUCTION RATE FOR A DEGREE OF OXYGEN SATURATION BEFORE THE TREATMENT WHICH TO BE RESPECTIVELY SUPERIOR IN 70%, 60% AND MORE.THE TUMOR THAT DEGREES OF OXYGEN SATURATION IN THE TUMOR INCREASE BY 10GY IRRADIATION (AFTER AN IRRADIATION START SEVERAL DAYS) SHOWS HIGH SENSITIVITY TOWARD THE RADIATION, AND SEEMS THAT IT CAN EXPECT AN EFFECTIVE TUMOR REDUCTION RATE.
RADIO-ACTIVE COMPOUNDS WHICH ACCUMULATE INTO THE HYPOXIC CELLS WERE DEVELOPED FOR THE PURPOSE OF NUN-INVASIVE MEASURING BY SPECT.A LOTS OF FUNDAMENTAL EXPERIMENTS WERE DONE TO PREPARE FOR THE PATENT APPLICATION.FOR ANOTHER METHOD TO RECOGNIZE HYPOXIC CELLS IN THE TUMOR, PIMONIDAZOLE WHICH ALSO ACCUMULATE INTO THE HYPOXIC CELLS WAS DETECTED BY IMMUNOHISTOCHEMISTRY WITH ANTI-PIMONIDAZOLE ANTIBODY.

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] 村山千恵子: "低酸素性細胞増感剤の現状"癌の臨床. 46. 301-305 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chieko Murayama, et al.: "Overcoming mutant p53 with hypoxic cell radiosensitizer,PR-350"Radiotherapy and Oncology. 56. S182 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 村山千恵子 他: "低酸素性細胞増感剤は変異型p53遺伝子発現腫瘍をより効果的に修飾できるか?"日本放射線腫瘍学会誌. 12. 299 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Chieko Murayama, et al.: "Hypoxic cell sensitizer,PR-350 : its radiosensitizing effects on the cells with different p53 status"Eur J Cancer. 35. S185 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 村山千恵子 他: "低酸素性細胞増感剤の効果におよぼすがん抑制遺伝子p53発現様式"日本放射線腫瘍学会誌. 11. 322 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 村山千恵子 他: "低酸素性細胞増感剤の効果におよぼすがん抑制遺伝子p53発現様式"日本医学放射線学会誌. 59. S109 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 村山千恵子 他: "ヌードマウス移植ヒト直腸癌に対する低酸素性細胞放射線増感剤PR-350の効果の検討"日本医学放射線学会誌. 59. 897 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 村山千恵子 他: "放射線増感剤CDDP併用放射線治療の最適プロトコールの検討"日本医学放射線学会誌. 58. S219 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] CHIEKO MURAYAMA: "CLINICAL EVALUATION OF HYPOXIC CELL SENSITIZERS."JPN J CANCER CLIN. 46. 301-305 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "OVERCOMING MUTANT P53 WITH HYPOXIC CELL RADIOSENSITIZER, PR-350."RADIOTHERAPY AND ONCOLOGY. 56. S182 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "THE EFFECT OF HYPOXIC CELL RADIOSENSITIZER IN WILD OR MUTANT P53 CELLS"J JPN SOC THER RADIOL ONCOL. 12. 299 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "HYPOXIC CELL SENSITIZER, PR-350 : ITS RADIOSENSITIZING EFFECTS ON THE CELLS WITH DIFFERENT P53 STATUS"EUR J CANCER. 35. S185 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "THE EFFECT OF HYPOXIC CELL RADIOSENSITIZER IN WILD OR MUTANT P53 CELLS"J JPN SOC THER RADIOL ONCOL. 11. 322 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "THE EFFECT OF HYPOXIC CELL RADIOSENSITIZER IN WILD OR MUTANT P53 CELLS"NIPPON ACT RADIOL. 59. S109 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "RADIOSENSITIZING EFFECT OF HYPOXIC CELL SENSITIZER, PR-350 IN HUMAN COLON CANCER CELLS"NIPPON ACT RADIOL. 59. 897 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] CHIEKO MURAYAMA, ET AL: "FUNDAMENTAL EVALUATION OF CDDP AS RADIOSENSITIZER ADEQUATE TO THE CLINICAL USE"NIPPON ACT RADIOL. 58. S219 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi